Search

Home > JACC Podcast > Monotherapy in HBR Patients: What STOPDAPT-3 Tells Us | JACC Baran
Podcast: JACC Podcast
Episode:

Monotherapy in HBR Patients: What STOPDAPT-3 Tells Us | JACC Baran
Category: Health
Duration: 00:31:30
Publish Date: 2025-06-24 13:57:36
Description:

Hosts Mitsuaki Sawano, MD, Kentaro Ejiri, MD, and Nobuhiro Ikemura, MD, welcome Yuki Obayashi, MD, of Leiden University Medical Center, to discuss findings from the STOPDAPT-3 trial. Dr. Obayashi highlights that, among ACS patients—including those with HBR or STEMI—aspirin and clopidogrel monotherapy after 1 month of DAPT resulted in similar rates of ischemic and bleeding events. These results support flexible, patient-centered antiplatelet strategies beyond the acute phase.
Total Play: 0

Some more Podcasts by American College of Cardiology

500+ Episodes
JACC: Clinic .. 10+     1
1K+ Episodes
JACC's Audio .. 70+     10+